Stevanato Group expands large-volume drug delivery offerings

Stevanato Group announced today that it expanded the capacity of its Vertiva on-body device for subcutaneous large-volume drug delivery.

The Italy-based company says its Vertiva platform now covers 10mL volumes. It plans to present the latest Vertiva development at CPhI Milan next month.

Vertiva features a single-use injection unit (or pod) and a multi-use smart controller. They communicate through a patented magnetically coupled drive mechanism. The interlocked pod contains a pre-filled glass cartridge, either in 3mL or 10mL format, loaded into the pod during factory assembly. This results in a ready-to-use device benefitting patients with simplified, safe and comfortable treatment initiation at home

Sign up for Blog Updates